Stockholders' Equity | Common Stock: Generally, the Company issues common stock in connection with acquisitions, as a part of equity financing transactions, as dividends on preferred stock, upon conversion of preferred shares to common stock and upon the exercise of stock options or warrants. There were no shares of common stock or warrants issued for equity financing during the three months ended June 30, 2016. During the six months ended June 30, 2016, the Company issued common stock and common stock warrants as a part of the following four equity financing transactions: On January 26, 2016, the Company entered into securities purchase agreements with a group of accredited investors, pursuant to which the Company was to issue 227,273 shares of common stock at a purchase price of $1.10 per share. In addition, the Company issued warrants to purchase up to 56,818 shares of the Corporations common stock in the aggregate, at an exercise price of $1.50 per share (the Warrants). The Warrants have a term of five years and may be exercised at any time from or after the date of issuance and contain customary, structural anti-dilution protection (i.e., stock splits, dividends, etc). Upon closing of this equity financing, the Company received proceeds of $250,000. On February 24, 2016, the Company received proceeds of $1,256,782 in connection with the Company's offer to amend and exercise warrants. In connection with the offering, warrant holders elected to exercise a total of 1,142,529 of their $1.125 warrants at a reduced exercise price of $1.10 per share. The Company issued new warrants to the participants to purchase 285,654 shares of common stock with a term of five (5) years and have an exercise price per share equal to $1.50. The Company incurred fees of $105,407 relative to this transaction. On March 3, 2016 the Company agreed to replace the 480,784 $1.50 warrants from the November 5, 2015, December 23, 2015 and January 26, 2016 financings with 1,923,137 five year warrants at $1.10 per share. These 1,923,137 warrants are subject to the Companys customary, structural anti-dilution protections (i.e. stock splits, dividends, etc). On March 10, 2016, the Company entered into securities purchase agreements with accredited investors, advisory clients of Wellington Management Company, LLP In the event, prior to March 10, 2021, the Company issues Additional Stock (as defined in the Qualified Purchasers Securities Purchase Agreement) for per share consideration that is less than the Exercise Price of the Qualified Purchaser warrants, then the Exercise Price of each Warrant shall be reduced concurrently with such issue, to match the per share price of the dilutive issuance. Additional Stock as defined in the Securities Purchase Agreement excludes common stock issued for exercises of stock options and warrants, conversions of promissory notes, and certain other adjustments as defined in the agreement. Additionally, in the event, prior to March 10, 2018, the Company issues Additional Stock for a per share consideration of less than $1.10 resulting in a Dilutive Issuance as defined in the Securities Purchase Agreement, the Company shall issue shares to the Qualified Purchasers, for no additional consideration, based on a formula defined in the Securities Purchase Agreement. Furthermore, in the event, prior to March 10, 2018, the Company issues Additional Stock (as defined in the Qualified Purchasers Warrant Agreement) the number of warrant shares shall be increased by the number of shares necessary to ensure that the Ownership Percentage immediately following the issuance of any such shares shall remain equal to the Ownership Percentage immediately prior to such issuance. Ownership Percentage is calculated as the 5,073,863 warrant shares issued to Qualified Investors divided by 141,538,754 fully diluted shares agreed upon at the issuance date. Additional stock per the Warrant Agreement excludes all of the same items described above and also excludes shares issued for a strategic investment between $10 million and $25 million. There was no activity during the three months ended June 30, 2016 to cause the above referenced dilutive or derivative features to be initiated. Qualified Purchasers cannot exercise their warrants unless their beneficial ownership of outstanding common stock falls below 9.9%. As of the March 10, 2016 issuance date and June 30, 2016, the Qualified Purchasers beneficially owned approximately 14% of the Companys common stock, thus, the warrants are not exercisable. If the Qualified Purchasers ownership of outstanding common stock falls below 9.9%, they are permitted to exercise warrants only to the extent that their beneficial ownership reaches 9.9%. Aside from legal fees, the Company incurred $397,699 in fees, plus the issuance of 202,955 $1.10 five year warrants, with an exercise price of $1.10 and in connection with this financing transaction and this amount is not reflected in the proceeds above. The table below summarizes the common stock and warrant activity referenced: Common Shares Warrants January 26, 2016 Securities Purchase Agreement 227,273 56,818 February 24, 2016 Warrant Exercises 1,142,529 (1,142,529) February 24, 2016 Warrant Issue 285,654 March 3, 2016 Warrants Replaced (480,784) March 3, 2016 Warrant Re-Issue 1,923,137 March 10, 2016 Stock Purchase Agreement 5,076,863 5,076,863 Warrants Issued for Services 202,955 Totals 6,446,665 5,922,114 7% Series B Convertible Preferred Stock: During 2010, the Company issued 1,200,000 shares of 7% Series B Convertible Preferred Stock (Series B Preferred Stock), along with 1,058,940 detachable warrants. The holders of shares of Series B Preferred Stock are entitled to receive a 7 percent annual dividend until the shares are converted to common stock. The warrants, immediately exercisable, are for a term of five years, and entitle the holder to purchase shares of common stock at an exercise price of $ 0.77 per share. During the three months ended March 31, 2015, 880,000 shares of Series B Preferred Stock were converted into 880,000 shares of common stock. As of June 30, 2016 and December 31, 2015, no shares of the Series B Preferred Stock remained outstanding. The Class B preferred stock accrued 7 percent per annum dividends. The dividends began accruing April 30, 2010, and were cumulative. Dividends were payable annually in arrears. At December 31, 2015, $6,857 of dividends had accrued on these shares. However, they are unrecorded on the Companys books until declared. On February 26, 2016, the Company declared the dividends on its Series B preferred stock accrued as of December 31, 2015, and the Company paid the dividends in 4,969 shares of Company common stock during the three months ended March 31, 2016. There were no accrued dividends payable as of June 30, 2016. Series C Convertible Preferred Stock: During 2011, the Company issued 2,380,952 shares of Series C Convertible Preferred Stock; $.001 par value per share (Series C Preferred Stock), along with 8,217,141 warrants. Each share was priced at $2.10 and, when issued, included 3 warrants at an exercise price of $0.77 which expire in 5 years. The Series C Preferred Stock (a) is convertible into three shares of common stock, subject to certain adjustments, (b) pays 7 percent dividends per annum, payable annually in cash or shares of common stock, at the Companys option, and (c) is automatically converted into common stock should the price of the Companys common stock exceed $2.50 for 30 consecutive trading days. The warrants issued in connection with the Series C Preferred Stock contain full-ratchet anti-dilution provisions that require them to be recorded as a derivative instrument. On August 11, 2015, the Company executed an Exchange Agreement with the holders of the Series C Preferred Stock Warrants, replacing the original $0.77 warrants, with $1.20 warrants, which are not eligible for exercise until after February 11, 2017 and have an expiration date of August 11, 2018. Additionally, the Company did not provide full-ratchet anti-dilution provisions. As of June 30, 2016 and December 31, 2015, 2,380,952 shares of the Series C Preferred Stock remain outstanding. On February 9, 2016, the Company entered into a letter agreement (the Agreement) with Miriam Blech and River Charitable Remainder Unitrust f/b/o Isaac Blech, who together control all of the Companys Class C Preferred Stock. Pursuant to the Agreement, the parties agreed to postpone payment of the annual dividend on the Companys Class C Preferred Stock until five (5) business days following the day on which the Company holds an annual or special meeting of its stockholders where the stockholders approve a proposal to increase the authorized capital stock of the Company. Associated with the March 10, 2016 financing, Mr. Isaac Blech and his affiliates agreed that the Company does not have to reserve shares of common stock for the conversion of their Series C Preferred Stock and underlying warrants until five (5) business days following the day on which the Company holds an annual or special meeting of its stockholders where the stockholders approve a proposal to increase the authorized capital stock of the Company. In addition, Mr. Blech and his affiliates agreed not to convert the Series C Preferred Stock or exercise the underlying warrants into shares of the Companys common stock, until such time as the Companys stockholders approve a proposal to increase the authorized capital stock of the Company. Stock Options: The Company issued 35,000 stock options during the three months ended June 30, 2016 and 260,000 stock options during the three months ended June 30, 2015 under the 2008 Stock Incentive Plan. The Companys results for the three months ended June 30, 2016 and 2015, include stock option based compensation expense of $201,433 and $161,867, respectively. These amounts are included within selling, general and administrative expenses on the Consolidated Statements of Operations. There were no tax benefits recognized with respect to that stock based compensation during the three months ended June 30, 2016 or 2015. The fair value of the 35,000 stock options granted during the three months ended June 30, 2016 were estimated using the Black Scholes option pricing model and using the following weighted-average assumptions: Exercise price $1.05 Risk free interest rate 2.39% Volatility 58.89% Expected term 5.5 Years Dividend yield None As of June 30, 2016 the Company has issued employees 2,114,000 contingent vesting options. The vesting of these options is contingent on shareholder approval of an increase in the amount of authorized shares of common stock. In the event that the shareholders do not approve the increase in authorized shares by December 7, 2016 the options will be cancelled. The Company has determined that due to the contingent vesting of these options, they are not included in the Companys outstanding stock options at June 30, 2016. The following table represents the activity under the stock incentive plan as of June 30, 2016 and the changes during each period: Options Shares Weighted Average Exercise Price Outstanding at December 31, 2014 11,309,864 $0.81 Issued 3,140,000 $1.37 Exercised (3,053,397) $0.66 Forfeitures (1,036,383) $1.07 Outstanding at December 31, 2015 10,360,084 $1.01 Issued 352,874 $1.31 Exercised (622,000) $0.63 Forfeitures (215,600) $1.11 Outstanding at June 30, 2016 9,875,358 $1.02 Warrants: On June 10, 2016 the Company exchanged 250,000 previously issued warrants for services provided by Board Members of the Company. These original warrants had 5 year terms maturing on June 10, 2016, had exercise prices of $1.05 per warrant and qualified for equity treatment. The replacement warrants also qualified for equity treatment and have 3 year terms with a strike price of $1.50 per warrant. The incremental fair value of the replacement warrants totaling $60,175 was recorded as stock compensation expense for the three months ended June 30, 2016. During the three months ended June 30, 2016, the Company issued 480,000 extension warrants to the holders of the Promissory Notes originally scheduled to expire May 21, 2016 (extended to May 21, 2017). Management determined that this transaction constituted a debt extinguishment under ASC 470 and the $226,380 fair value of the warrants was recorded as a loss on extinguishment in the accompanying consolidated statement of operations for the three months ended June 30, 2016. No warrants to purchase common stock were exercised during the three months ended June 30, 2016. The following table represents the warrant activity as of June 30, 2016 and the changes during each period: Warrants Shares Weighted Average Exercise Outstanding at December 31, 2014 18,753,060 $1.06 Issued 15,848,643 $1.09 Exercised (1,546,308) $0.76 Cancelled (7,187,642) $0.80 Outstanding at December 31, 2015 25,867,753 $1.16 Issued 8,218,609 $1.13 Exercised (1,712,529) $0.99 Cancelled (1,684,595) $2.46 Outstanding at June 30, 2016 30,689,238 $1.09 |